Skip to main content
SpringerLink
Log in

Tigecycline-induced coagulopathy: a literature review

  • Letter to the Editor
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cui N, Cai H, Li Z, et al. Tigecycline-induced coagulopathy: a literature review. Int J Clin Pharm. 2019;41:1408–13.

    Article  Google Scholar 

  2. Zhang Q, Zhou S, Zhou J. Tigecycline treatment causes a decrease in fibrinogen levels. Antimicrob Agents Chemother. 2015;59:1650–5.

    Article  Google Scholar 

  3. Hakeam HA, Al Duhailib Z, Salahuddin N, Amin T. Impact of tigecycline versus imipenem–cilastatin on fibrinogen levels following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a randomized-controlled study. J Chemother. 2018;30:224–32.

    Article  CAS  Google Scholar 

  4. Neerman-Arbez M, Casini A. Clinical consequences and molecular bases of low fibrinogen levels. Int J Mol Sci. 2018;19:192.

    Article  Google Scholar 

  5. Balfousias T, Apostolopoulos AP, Angelis S, et al. Spontaneous knee hemarthrosis due to hypofibrinogenemia following tigecycline treatment for periprosthetic joint infection. Cureus. 2019;11:e5883.

    PubMed  PubMed Central  Google Scholar 

  6. Sabanis N, Paschou E, Gavriilaki E, et al. Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder. Infect Dis (Lond). 2015;47:743–6.

    Article  Google Scholar 

  7. Ahmed S, Oropello JM. Critical care issues in oncological surgery patients. Crit Care Clin. 2010;26:93–106.

    Article  Google Scholar 

Download references

Funding

Nothing to be reported.

Author information

Authors and Affiliations

  1. Pharmaceutical Care Division, King Faisal Specialist Hospital & Research Centre, MBC# 11, P.O. Box 3354, Riyadh, 11211, Saudi Arabia

    Hakeam A. Hakeam

  2. College of Medicine, Alfaisal University, Riyadh, Saudi Arabia

    Hakeam A. Hakeam

  3. Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada

    Zainab Al Duhailib

  4. Department of Critical Care Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

    Zainab Al Duhailib

Authors
  1. Hakeam A. Hakeam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zainab Al Duhailib
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hakeam A. Hakeam.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hakeam, H.A., Al Duhailib, Z. Tigecycline-induced coagulopathy: a literature review. Int J Clin Pharm 42, 846–847 (2020). https://doi.org/10.1007/s11096-020-00974-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-020-00974-w

Search

Navigation